Squamous Cell Lung Carcinoma Latest Advances

Find the Latest Research About Squamous Cell Lung Carcinoma

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2945 publications

Prognostic Significance and Classification Value of Tumor Budding, Single Cell Invasion, and Spread Through Airspaces (STAS) in Lung Squamous Cell Carcinoma.

Prognostic Significance and Classification Value of Tumor Budding, Single Cell Invasion, and Spread Through Airspaces (STAS) in Lung Squamous Cell Carcinoma.

Journal: International journal of surgical pathology
Published: June 11, 2026

Immoderate perfume use leading to non-keratinising sinonasal squamous cell carcinoma with bone and lung metastases.

Immoderate perfume use leading to non-keratinising sinonasal squamous cell carcinoma with bone and lung metastases.

Journal: JPMA. The Journal of the Pakistan Medical Association
Published: June 09, 2026

p40-positive metastatic urothelial carcinoma mimicking primary pulmonary squamous cell carcinoma on limited lung biopsy.

p40-positive metastatic urothelial carcinoma mimicking primary pulmonary squamous cell carcinoma on limited lung biopsy.

Journal: BMJ case reports
Published: June 01, 2026

Correction to "Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma".

Correction to "Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma".

Journal: Oxidative medicine and cellular longevity
Published: May 17, 2026

The lncRNA ZNF295-AS1 alleviates lung squamous cell carcinoma progression by reducing miR-96-5p and inhibiting cancer cell invasiveness.

The lncRNA ZNF295-AS1 alleviates lung squamous cell carcinoma progression by reducing miR-96-5p and inhibiting cancer cell invasiveness.

Journal: RNA biology
Published: May 14, 2026

Preliminary Analysis of Tumor Immune Microenvironment Characteristics
in Lung Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy 
Based on Single-cell Transcriptomics

Preliminary Analysis of Tumor Immune Microenvironment Characteristics
in Lung Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy 
Based on Single-cell Transcriptomics

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: May 13, 2026

Solitary Parotid Metastasis as an Atypical Site of Recurrence in Lung Squamous Cell Carcinoma: A Diagnostic Difficulty.

Solitary Parotid Metastasis as an Atypical Site of Recurrence in Lung Squamous Cell Carcinoma: A Diagnostic Difficulty.

Journal: Cureus
Published: April 30, 2026

PET/CT Radiomics-based assessment of tumor heterogeneity for predicting immunotherapy outcomes in advanced lung squamous cell carcinoma: a retrospective prognostic modeling study.

PET/CT Radiomics-based assessment of tumor heterogeneity for predicting immunotherapy outcomes in advanced lung squamous cell carcinoma: a retrospective prognostic modeling study.

Journal: BMC cancer
Published: April 25, 2026

Are There CT Imaging Features That Can Distinguish Primary Pulmonary Squamous Cell Carcinoma from Solitary Lung Metastasis of Head and Neck Squamous Cell Carcinoma?

Are There CT Imaging Features That Can Distinguish Primary Pulmonary Squamous Cell Carcinoma from Solitary Lung Metastasis of Head and Neck Squamous Cell Carcinoma?

Journal: Cancers
Published: April 24, 2026

Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation.

Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation.

Journal: Combinatorial chemistry & high throughput screening
Published: April 20, 2026

Squamous Cell Carcinoma of the Lung Masquerading as Pulmonary Mucormycosis.

Squamous Cell Carcinoma of the Lung Masquerading as Pulmonary Mucormycosis.

Journal: The Annals of thoracic surgery
Published: April 07, 2026

HSR26-216: High LDH-to-Albumin Ratio (LAR) May Represent a Poor Prognostic Marker in Patients With Squamous Cell Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.

HSR26-216: High LDH-to-Albumin Ratio (LAR) May Represent a Poor Prognostic Marker in Patients With Squamous Cell Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
Showing 1-12 of 2,945

Last Updated: 06/30/2026